About Us2.ai
Us2.ai is a healthcare AI company dedicated to transforming cardiovascular care through the development of deep learning solutions applied to ultrasound medical imaging biomarkers. Their mission is to democratize expert-level cardiac diagnostics by making echocardiogram analysis faster, more accurate, and accessible to healthcare providers globally. The company’s AI-powered software, including their flagship product Echo Copilot and Us2.v1/Us2.v2, automates the analysis of echocardiograms, providing fully automated, real-time reports on heart structure and function.
For physicians, Us2.ai’s technology offers significant workflow efficiencies by eliminating the need for manual frame selection and annotation, and by generating comprehensive, editable reports with measurements, disease detection, and clinical findings for all heart chambers using both 2D and Doppler views. This automation helps in the detection of various heart-related conditions such as heart failure, pulmonary hypertension, aortic stenosis, and cardiac amyloidosis, aligning with international guidelines. The software is FDA 510(k) cleared and CE Marked, and can be integrated seamlessly with existing echo devices, PACS, and EMR systems, allowing clinicians to focus on image quality and patient care while the AI processes the data in the background.
Focus Areas
Business Intelligence
| Technology | Cloud-native, deep learning, AI-powered echocardiography analysis, fully automated, integrates with ultrasound devices and PACS, delivers structured reports, real-time processing, explainable AI output |
What Physicians Need to Know
For physicians, Us2.ai can significantly reduce reporting time by up to 70%, allowing for faster diagnoses (from 35-40 minutes down to approximately 10 minutes) and increased daily scan volume. The 100% automation minimizes manual workload, allowing sonographers to focus on image quality. The platform's vendor-neutrality ensures it integrates seamlessly with existing ultrasound devices and PACS, CVIS, or EMR systems without requiring changes to acquisition protocols. The explainable AI outcomes, with guideline-referenced measurements traceable to contour and beat, provide confidence and allow for direct editing from the report. This can lead to more consistent and objective measurements, improving decision-making.
Us2.ai is designed for flexible and vendor-neutral integration. It is DICOM-native and can be deployed in four main ways: bundled with an ultrasound system (OEM), through an AI marketplace, directly into cardiology PACS/reporting systems, or via cloud and API for research and core-lab use. It integrates with major ultrasound vendors like GE, Philips, Siemens, and Canon, as well as handheld POCUS devices. Partnerships include Fujifilm, Viz.ai, and Merge, allowing for seamless integration into existing clinical workflows and platforms like Merge Cardio. The system delivers structured reports as DICOM-SR, HL7, or PDF into PACS, AI platforms, or reporting systems. Us2.ai is GDPR and HIPAA compliant, ISO 27001:2022 certified, SOC 2 Type II attested, and MDSAP certified, ensuring secure and compliant deployment.
What the Web Says
Us2.ai is a company that specializes in AI-powered echocardiography analysis, aiming to make cardiovascular imaging more efficient and accessible. Their FDA-cleared software analyzes echocardiograms from any ultrasound machine, providing measurements and a draft report in under two minutes. Reviews suggest the product significantly reduces reporting time and improves workflow efficiency for cardiologists and sonographers.
Overall: PositiveStrengths
- Faster and more consistent echo reports.
- Reduces diagnosis time per study by up to 70%.
- Improves measurement accuracy and workflow efficiency.
- Vendor-neutral, working with ultrasound machines from any maker.
- Preserves clinical autonomy by allowing review and editing of AI-generated measurements.
- Detects disease, not just measures.
Limitations
- Weak fit for sites that read only a handful of echoes a week.
- Not suitable for buyers who want AI for CT, MRI, or X-ray in the same purchase.
- Lack of a published price list.
- No specific employer reviews found on Glassdoor.
- No specific product reviews found on G2 or Capterra.
- Limited information on Reddit specifically for Us2.ai product or employer reviews.
Based on reviews from: Healthcare Industry Reviews (Vertex AI Search), Us2.ai Testimonials, Us2.ai User Perceptions of AI Echo, G2, Us2.ai How to Evaluate AI Echocardiography Platforms, Us2.ai Products, Us2.ai AI Echocardiography Reporting Software, FDA-Cleared, Us2.ai How Us2.ai and Merge Are Bringing AI Echo Directly Into Clinical Workflows, Reddit r/cardiacsonography, Us2.ai What Should You Demand from AI Echocardiography?, Us2.ai AI in Echo: State-of-the-art Automated Measurement Techniques and Clinical Applications, Us2.ai AI Echo Lab Efficiency: 70% Faster Reporting
Last updated: 2026-10-21
Videos
News, demos, and interviews about Us2.ai.
Videos load interactively. If none appear, search YouTube for Us2.ai →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]
CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (AI) technologies for capsule endoscopy solutions. Their primary goal is to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. [7] Their flagship product, the CapsoCam Plus system, is a single-use capsule endoscope equipped with four cameras, providing […]